nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—ABCB1—Mitomycin—stomach cancer	0.127	0.581	CbGbCtD
Amantadine—ABCB1—Irinotecan—stomach cancer	0.0326	0.149	CbGbCtD
Amantadine—ABCB1—Docetaxel—stomach cancer	0.0239	0.109	CbGbCtD
Amantadine—ABCB1—Doxorubicin—stomach cancer	0.0178	0.0814	CbGbCtD
Amantadine—ABCB1—Methotrexate—stomach cancer	0.0173	0.0789	CbGbCtD
Amantadine—Liver function test abnormal—Doxorubicin—stomach cancer	0.000777	0.00153	CcSEcCtD
Amantadine—Orthostatic hypotension—Doxorubicin—stomach cancer	0.000769	0.00152	CcSEcCtD
Amantadine—Photosensitivity reaction—Methotrexate—stomach cancer	0.000767	0.00151	CcSEcCtD
Amantadine—Body temperature increased—Irinotecan—stomach cancer	0.000758	0.00149	CcSEcCtD
Amantadine—Feeling abnormal—Fluorouracil—stomach cancer	0.000757	0.00149	CcSEcCtD
Amantadine—Vision blurred—Capecitabine—stomach cancer	0.000741	0.00146	CcSEcCtD
Amantadine—Tremor—Capecitabine—stomach cancer	0.000737	0.00145	CcSEcCtD
Amantadine—Neutropenia—Epirubicin—stomach cancer	0.000736	0.00145	CcSEcCtD
Amantadine—Dysphagia—Doxorubicin—stomach cancer	0.000728	0.00143	CcSEcCtD
Amantadine—Leukopenia—Docetaxel—stomach cancer	0.000727	0.00143	CcSEcCtD
Amantadine—Body temperature increased—Fluorouracil—stomach cancer	0.000726	0.00143	CcSEcCtD
Amantadine—Palpitations—Docetaxel—stomach cancer	0.000718	0.00141	CcSEcCtD
Amantadine—Photosensitivity reaction—Epirubicin—stomach cancer	0.000718	0.00141	CcSEcCtD
Amantadine—Hypersensitivity—Irinotecan—stomach cancer	0.000707	0.00139	CcSEcCtD
Amantadine—Leukopenia—Capecitabine—stomach cancer	0.000704	0.00139	CcSEcCtD
Amantadine—Convulsion—Docetaxel—stomach cancer	0.000704	0.00139	CcSEcCtD
Amantadine—Hypertension—Docetaxel—stomach cancer	0.000702	0.00138	CcSEcCtD
Amantadine—Agranulocytosis—Methotrexate—stomach cancer	0.000699	0.00138	CcSEcCtD
Amantadine—Palpitations—Capecitabine—stomach cancer	0.000695	0.00137	CcSEcCtD
Amantadine—Asthenia—Irinotecan—stomach cancer	0.000688	0.00136	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000687	0.00135	CcSEcCtD
Amantadine—Neutropenia—Doxorubicin—stomach cancer	0.000681	0.00134	CcSEcCtD
Amantadine—Hypertension—Capecitabine—stomach cancer	0.000679	0.00134	CcSEcCtD
Amantadine—Hypersensitivity—Fluorouracil—stomach cancer	0.000677	0.00133	CcSEcCtD
Amantadine—Dry mouth—Docetaxel—stomach cancer	0.000677	0.00133	CcSEcCtD
Amantadine—Confusional state—Docetaxel—stomach cancer	0.000669	0.00132	CcSEcCtD
Amantadine—Anxiety—Capecitabine—stomach cancer	0.000668	0.00131	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000665	0.00131	CcSEcCtD
Amantadine—Urinary tract disorder—Methotrexate—stomach cancer	0.000664	0.00131	CcSEcCtD
Amantadine—Photosensitivity reaction—Doxorubicin—stomach cancer	0.000664	0.00131	CcSEcCtD
Amantadine—Anaphylactic shock—Docetaxel—stomach cancer	0.000663	0.00131	CcSEcCtD
Amantadine—Oedema—Docetaxel—stomach cancer	0.000663	0.00131	CcSEcCtD
Amantadine—Urethral disorder—Methotrexate—stomach cancer	0.00066	0.0013	CcSEcCtD
Amantadine—Diarrhoea—Irinotecan—stomach cancer	0.000656	0.00129	CcSEcCtD
Amantadine—Dry mouth—Capecitabine—stomach cancer	0.000655	0.00129	CcSEcCtD
Amantadine—Agranulocytosis—Epirubicin—stomach cancer	0.000655	0.00129	CcSEcCtD
Amantadine—Nervous system disorder—Docetaxel—stomach cancer	0.00065	0.00128	CcSEcCtD
Amantadine—Pruritus—Fluorouracil—stomach cancer	0.00065	0.00128	CcSEcCtD
Amantadine—Visual impairment—Methotrexate—stomach cancer	0.000648	0.00128	CcSEcCtD
Amantadine—Confusional state—Capecitabine—stomach cancer	0.000647	0.00128	CcSEcCtD
Amantadine—Tachycardia—Docetaxel—stomach cancer	0.000647	0.00128	CcSEcCtD
Amantadine—Skin disorder—Docetaxel—stomach cancer	0.000644	0.00127	CcSEcCtD
Amantadine—Oedema—Capecitabine—stomach cancer	0.000642	0.00126	CcSEcCtD
Amantadine—Dizziness—Irinotecan—stomach cancer	0.000634	0.00125	CcSEcCtD
Amantadine—Anorexia—Docetaxel—stomach cancer	0.000632	0.00125	CcSEcCtD
Amantadine—Nervous system disorder—Capecitabine—stomach cancer	0.00063	0.00124	CcSEcCtD
Amantadine—Eye disorder—Methotrexate—stomach cancer	0.000629	0.00124	CcSEcCtD
Amantadine—Diarrhoea—Fluorouracil—stomach cancer	0.000629	0.00124	CcSEcCtD
Amantadine—Tachycardia—Capecitabine—stomach cancer	0.000627	0.00123	CcSEcCtD
Amantadine—Cardiac disorder—Methotrexate—stomach cancer	0.000624	0.00123	CcSEcCtD
Amantadine—Skin disorder—Capecitabine—stomach cancer	0.000624	0.00123	CcSEcCtD
Amantadine—Urinary tract disorder—Epirubicin—stomach cancer	0.000622	0.00122	CcSEcCtD
Amantadine—Hyperhidrosis—Capecitabine—stomach cancer	0.000621	0.00122	CcSEcCtD
Amantadine—Oedema peripheral—Epirubicin—stomach cancer	0.00062	0.00122	CcSEcCtD
Amantadine—Hypotension—Docetaxel—stomach cancer	0.00062	0.00122	CcSEcCtD
Amantadine—Urethral disorder—Epirubicin—stomach cancer	0.000617	0.00122	CcSEcCtD
Amantadine—Anorexia—Capecitabine—stomach cancer	0.000612	0.00121	CcSEcCtD
Amantadine—Angiopathy—Methotrexate—stomach cancer	0.00061	0.0012	CcSEcCtD
Amantadine—Vomiting—Irinotecan—stomach cancer	0.00061	0.0012	CcSEcCtD
Amantadine—Dizziness—Fluorouracil—stomach cancer	0.000608	0.0012	CcSEcCtD
Amantadine—Visual impairment—Epirubicin—stomach cancer	0.000607	0.0012	CcSEcCtD
Amantadine—Mediastinal disorder—Methotrexate—stomach cancer	0.000606	0.00119	CcSEcCtD
Amantadine—Agranulocytosis—Doxorubicin—stomach cancer	0.000606	0.00119	CcSEcCtD
Amantadine—Rash—Irinotecan—stomach cancer	0.000605	0.00119	CcSEcCtD
Amantadine—Dermatitis—Irinotecan—stomach cancer	0.000604	0.00119	CcSEcCtD
Amantadine—Headache—Irinotecan—stomach cancer	0.000601	0.00118	CcSEcCtD
Amantadine—Hypotension—Capecitabine—stomach cancer	0.0006	0.00118	CcSEcCtD
Amantadine—Insomnia—Docetaxel—stomach cancer	0.0006	0.00118	CcSEcCtD
Amantadine—Paraesthesia—Docetaxel—stomach cancer	0.000596	0.00117	CcSEcCtD
Amantadine—Alopecia—Methotrexate—stomach cancer	0.000595	0.00117	CcSEcCtD
Amantadine—Dyspnoea—Docetaxel—stomach cancer	0.000591	0.00116	CcSEcCtD
Amantadine—Somnolence—Docetaxel—stomach cancer	0.00059	0.00116	CcSEcCtD
Amantadine—Mental disorder—Methotrexate—stomach cancer	0.000589	0.00116	CcSEcCtD
Amantadine—Eye disorder—Epirubicin—stomach cancer	0.000588	0.00116	CcSEcCtD
Amantadine—Malnutrition—Methotrexate—stomach cancer	0.000586	0.00115	CcSEcCtD
Amantadine—Cardiac disorder—Epirubicin—stomach cancer	0.000584	0.00115	CcSEcCtD
Amantadine—Vomiting—Fluorouracil—stomach cancer	0.000584	0.00115	CcSEcCtD
Amantadine—Dyspepsia—Docetaxel—stomach cancer	0.000584	0.00115	CcSEcCtD
Amantadine—Insomnia—Capecitabine—stomach cancer	0.000581	0.00114	CcSEcCtD
Amantadine—Rash—Fluorouracil—stomach cancer	0.000579	0.00114	CcSEcCtD
Amantadine—Dermatitis—Fluorouracil—stomach cancer	0.000579	0.00114	CcSEcCtD
Amantadine—Paraesthesia—Capecitabine—stomach cancer	0.000577	0.00114	CcSEcCtD
Amantadine—Decreased appetite—Docetaxel—stomach cancer	0.000577	0.00114	CcSEcCtD
Amantadine—Headache—Fluorouracil—stomach cancer	0.000576	0.00113	CcSEcCtD
Amantadine—Urinary tract disorder—Doxorubicin—stomach cancer	0.000575	0.00113	CcSEcCtD
Amantadine—Oedema peripheral—Doxorubicin—stomach cancer	0.000574	0.00113	CcSEcCtD
Amantadine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000573	0.00113	CcSEcCtD
Amantadine—Dyspnoea—Capecitabine—stomach cancer	0.000572	0.00113	CcSEcCtD
Amantadine—Fatigue—Docetaxel—stomach cancer	0.000572	0.00113	CcSEcCtD
Amantadine—Angiopathy—Epirubicin—stomach cancer	0.000571	0.00113	CcSEcCtD
Amantadine—Urethral disorder—Doxorubicin—stomach cancer	0.000571	0.00113	CcSEcCtD
Amantadine—Nausea—Irinotecan—stomach cancer	0.00057	0.00112	CcSEcCtD
Amantadine—Mediastinal disorder—Epirubicin—stomach cancer	0.000567	0.00112	CcSEcCtD
Amantadine—Constipation—Docetaxel—stomach cancer	0.000567	0.00112	CcSEcCtD
Amantadine—Dyspepsia—Capecitabine—stomach cancer	0.000565	0.00111	CcSEcCtD
Amantadine—Arrhythmia—Epirubicin—stomach cancer	0.000562	0.00111	CcSEcCtD
Amantadine—Visual impairment—Doxorubicin—stomach cancer	0.000561	0.00111	CcSEcCtD
Amantadine—Decreased appetite—Capecitabine—stomach cancer	0.000558	0.0011	CcSEcCtD
Amantadine—Alopecia—Epirubicin—stomach cancer	0.000556	0.0011	CcSEcCtD
Amantadine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000554	0.00109	CcSEcCtD
Amantadine—Fatigue—Capecitabine—stomach cancer	0.000554	0.00109	CcSEcCtD
Amantadine—Vision blurred—Methotrexate—stomach cancer	0.000552	0.00109	CcSEcCtD
Amantadine—Mental disorder—Epirubicin—stomach cancer	0.000552	0.00109	CcSEcCtD
Amantadine—Constipation—Capecitabine—stomach cancer	0.000549	0.00108	CcSEcCtD
Amantadine—Malnutrition—Epirubicin—stomach cancer	0.000548	0.00108	CcSEcCtD
Amantadine—Feeling abnormal—Docetaxel—stomach cancer	0.000547	0.00108	CcSEcCtD
Amantadine—Nausea—Fluorouracil—stomach cancer	0.000546	0.00108	CcSEcCtD
Amantadine—Eye disorder—Doxorubicin—stomach cancer	0.000544	0.00107	CcSEcCtD
Amantadine—Cardiac disorder—Doxorubicin—stomach cancer	0.000541	0.00107	CcSEcCtD
Amantadine—Tension—Epirubicin—stomach cancer	0.000538	0.00106	CcSEcCtD
Amantadine—Nervousness—Epirubicin—stomach cancer	0.000532	0.00105	CcSEcCtD
Amantadine—Feeling abnormal—Capecitabine—stomach cancer	0.000529	0.00104	CcSEcCtD
Amantadine—Angiopathy—Doxorubicin—stomach cancer	0.000529	0.00104	CcSEcCtD
Amantadine—Mediastinal disorder—Doxorubicin—stomach cancer	0.000525	0.00103	CcSEcCtD
Amantadine—Body temperature increased—Docetaxel—stomach cancer	0.000524	0.00103	CcSEcCtD
Amantadine—Leukopenia—Methotrexate—stomach cancer	0.000524	0.00103	CcSEcCtD
Amantadine—Arrhythmia—Doxorubicin—stomach cancer	0.00052	0.00103	CcSEcCtD
Amantadine—Vision blurred—Epirubicin—stomach cancer	0.000517	0.00102	CcSEcCtD
Amantadine—Alopecia—Doxorubicin—stomach cancer	0.000515	0.00101	CcSEcCtD
Amantadine—Mental disorder—Doxorubicin—stomach cancer	0.00051	0.00101	CcSEcCtD
Amantadine—Body temperature increased—Capecitabine—stomach cancer	0.000508	0.001	CcSEcCtD
Amantadine—Convulsion—Methotrexate—stomach cancer	0.000507	0.001	CcSEcCtD
Amantadine—Malnutrition—Doxorubicin—stomach cancer	0.000507	0.000999	CcSEcCtD
Amantadine—Agitation—Epirubicin—stomach cancer	0.000504	0.000992	CcSEcCtD
Amantadine—Tension—Doxorubicin—stomach cancer	0.000498	0.00098	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000495	0.000976	CcSEcCtD
Amantadine—Nervousness—Doxorubicin—stomach cancer	0.000493	0.00097	CcSEcCtD
Amantadine—Leukopenia—Epirubicin—stomach cancer	0.000491	0.000967	CcSEcCtD
Amantadine—Hypersensitivity—Docetaxel—stomach cancer	0.000489	0.000963	CcSEcCtD
Amantadine—Palpitations—Epirubicin—stomach cancer	0.000484	0.000954	CcSEcCtD
Amantadine—Confusional state—Methotrexate—stomach cancer	0.000482	0.000949	CcSEcCtD
Amantadine—Anaphylactic shock—Methotrexate—stomach cancer	0.000478	0.000942	CcSEcCtD
Amantadine—Vision blurred—Doxorubicin—stomach cancer	0.000478	0.000942	CcSEcCtD
Amantadine—Asthenia—Docetaxel—stomach cancer	0.000476	0.000937	CcSEcCtD
Amantadine—Convulsion—Epirubicin—stomach cancer	0.000475	0.000936	CcSEcCtD
Amantadine—Hypertension—Epirubicin—stomach cancer	0.000473	0.000932	CcSEcCtD
Amantadine—Hypersensitivity—Capecitabine—stomach cancer	0.000473	0.000932	CcSEcCtD
Amantadine—Pruritus—Docetaxel—stomach cancer	0.000469	0.000924	CcSEcCtD
Amantadine—Nervous system disorder—Methotrexate—stomach cancer	0.000469	0.000923	CcSEcCtD
Amantadine—Agitation—Doxorubicin—stomach cancer	0.000466	0.000918	CcSEcCtD
Amantadine—Anxiety—Epirubicin—stomach cancer	0.000465	0.000916	CcSEcCtD
Amantadine—Skin disorder—Methotrexate—stomach cancer	0.000464	0.000915	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000463	0.000913	CcSEcCtD
Amantadine—Hyperhidrosis—Methotrexate—stomach cancer	0.000462	0.00091	CcSEcCtD
Amantadine—Asthenia—Capecitabine—stomach cancer	0.000461	0.000908	CcSEcCtD
Amantadine—Dry mouth—Epirubicin—stomach cancer	0.000456	0.000899	CcSEcCtD
Amantadine—Anorexia—Methotrexate—stomach cancer	0.000456	0.000898	CcSEcCtD
Amantadine—Pruritus—Capecitabine—stomach cancer	0.000454	0.000895	CcSEcCtD
Amantadine—Leukopenia—Doxorubicin—stomach cancer	0.000454	0.000894	CcSEcCtD
Amantadine—Diarrhoea—Docetaxel—stomach cancer	0.000454	0.000894	CcSEcCtD
Amantadine—Confusional state—Epirubicin—stomach cancer	0.000451	0.000889	CcSEcCtD
Amantadine—Palpitations—Doxorubicin—stomach cancer	0.000448	0.000883	CcSEcCtD
Amantadine—Anaphylactic shock—Epirubicin—stomach cancer	0.000447	0.000881	CcSEcCtD
Amantadine—Oedema—Epirubicin—stomach cancer	0.000447	0.000881	CcSEcCtD
Amantadine—Hypotension—Methotrexate—stomach cancer	0.000447	0.00088	CcSEcCtD
Amantadine—Convulsion—Doxorubicin—stomach cancer	0.000439	0.000866	CcSEcCtD
Amantadine—Diarrhoea—Capecitabine—stomach cancer	0.000439	0.000865	CcSEcCtD
Amantadine—Nervous system disorder—Epirubicin—stomach cancer	0.000439	0.000864	CcSEcCtD
Amantadine—Dizziness—Docetaxel—stomach cancer	0.000439	0.000864	CcSEcCtD
Amantadine—Hypertension—Doxorubicin—stomach cancer	0.000438	0.000863	CcSEcCtD
Amantadine—Tachycardia—Epirubicin—stomach cancer	0.000437	0.00086	CcSEcCtD
Amantadine—Skin disorder—Epirubicin—stomach cancer	0.000435	0.000856	CcSEcCtD
Amantadine—Hyperhidrosis—Epirubicin—stomach cancer	0.000432	0.000852	CcSEcCtD
Amantadine—Insomnia—Methotrexate—stomach cancer	0.000432	0.000852	CcSEcCtD
Amantadine—Anxiety—Doxorubicin—stomach cancer	0.00043	0.000848	CcSEcCtD
Amantadine—Paraesthesia—Methotrexate—stomach cancer	0.000429	0.000846	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000429	0.000845	CcSEcCtD
Amantadine—Anorexia—Epirubicin—stomach cancer	0.000426	0.00084	CcSEcCtD
Amantadine—Dyspnoea—Methotrexate—stomach cancer	0.000426	0.00084	CcSEcCtD
Amantadine—Somnolence—Methotrexate—stomach cancer	0.000425	0.000837	CcSEcCtD
Amantadine—Dizziness—Capecitabine—stomach cancer	0.000425	0.000836	CcSEcCtD
Amantadine—Dry mouth—Doxorubicin—stomach cancer	0.000422	0.000832	CcSEcCtD
Amantadine—Vomiting—Docetaxel—stomach cancer	0.000422	0.000831	CcSEcCtD
Amantadine—Dyspepsia—Methotrexate—stomach cancer	0.000421	0.000829	CcSEcCtD
Amantadine—Rash—Docetaxel—stomach cancer	0.000418	0.000824	CcSEcCtD
Amantadine—Hypotension—Epirubicin—stomach cancer	0.000418	0.000823	CcSEcCtD
Amantadine—Dermatitis—Docetaxel—stomach cancer	0.000418	0.000823	CcSEcCtD
Amantadine—Confusional state—Doxorubicin—stomach cancer	0.000417	0.000822	CcSEcCtD
Amantadine—Decreased appetite—Methotrexate—stomach cancer	0.000416	0.000819	CcSEcCtD
Amantadine—Headache—Docetaxel—stomach cancer	0.000415	0.000818	CcSEcCtD
Amantadine—Anaphylactic shock—Doxorubicin—stomach cancer	0.000414	0.000815	CcSEcCtD
Amantadine—Oedema—Doxorubicin—stomach cancer	0.000414	0.000815	CcSEcCtD
Amantadine—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000413	0.000813	CcSEcCtD
Amantadine—Fatigue—Methotrexate—stomach cancer	0.000412	0.000812	CcSEcCtD
Amantadine—Vomiting—Capecitabine—stomach cancer	0.000408	0.000804	CcSEcCtD
Amantadine—Nervous system disorder—Doxorubicin—stomach cancer	0.000406	0.0008	CcSEcCtD
Amantadine—Rash—Capecitabine—stomach cancer	0.000405	0.000798	CcSEcCtD
Amantadine—Insomnia—Epirubicin—stomach cancer	0.000405	0.000797	CcSEcCtD
Amantadine—Dermatitis—Capecitabine—stomach cancer	0.000404	0.000797	CcSEcCtD
Amantadine—Tachycardia—Doxorubicin—stomach cancer	0.000404	0.000796	CcSEcCtD
Amantadine—Headache—Capecitabine—stomach cancer	0.000402	0.000792	CcSEcCtD
Amantadine—Skin disorder—Doxorubicin—stomach cancer	0.000402	0.000792	CcSEcCtD
Amantadine—Paraesthesia—Epirubicin—stomach cancer	0.000402	0.000791	CcSEcCtD
Amantadine—Hyperhidrosis—Doxorubicin—stomach cancer	0.0004	0.000788	CcSEcCtD
Amantadine—Dyspnoea—Epirubicin—stomach cancer	0.000399	0.000786	CcSEcCtD
Amantadine—Somnolence—Epirubicin—stomach cancer	0.000398	0.000783	CcSEcCtD
Amantadine—Anorexia—Doxorubicin—stomach cancer	0.000395	0.000777	CcSEcCtD
Amantadine—Nausea—Docetaxel—stomach cancer	0.000394	0.000776	CcSEcCtD
Amantadine—Feeling abnormal—Methotrexate—stomach cancer	0.000394	0.000776	CcSEcCtD
Amantadine—Dyspepsia—Epirubicin—stomach cancer	0.000394	0.000776	CcSEcCtD
Amantadine—Decreased appetite—Epirubicin—stomach cancer	0.000389	0.000766	CcSEcCtD
Amantadine—Hypotension—Doxorubicin—stomach cancer	0.000387	0.000762	CcSEcCtD
Amantadine—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000386	0.000761	CcSEcCtD
Amantadine—Fatigue—Epirubicin—stomach cancer	0.000386	0.00076	CcSEcCtD
Amantadine—Constipation—Epirubicin—stomach cancer	0.000383	0.000754	CcSEcCtD
Amantadine—Nausea—Capecitabine—stomach cancer	0.000381	0.000751	CcSEcCtD
Amantadine—Body temperature increased—Methotrexate—stomach cancer	0.000378	0.000744	CcSEcCtD
Amantadine—Insomnia—Doxorubicin—stomach cancer	0.000374	0.000737	CcSEcCtD
Amantadine—Paraesthesia—Doxorubicin—stomach cancer	0.000372	0.000732	CcSEcCtD
Amantadine—Dyspnoea—Doxorubicin—stomach cancer	0.000369	0.000727	CcSEcCtD
Amantadine—Feeling abnormal—Epirubicin—stomach cancer	0.000369	0.000726	CcSEcCtD
Amantadine—Somnolence—Doxorubicin—stomach cancer	0.000368	0.000725	CcSEcCtD
Amantadine—Dyspepsia—Doxorubicin—stomach cancer	0.000364	0.000718	CcSEcCtD
Amantadine—Decreased appetite—Doxorubicin—stomach cancer	0.00036	0.000709	CcSEcCtD
Amantadine—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000357	0.000704	CcSEcCtD
Amantadine—Fatigue—Doxorubicin—stomach cancer	0.000357	0.000703	CcSEcCtD
Amantadine—Constipation—Doxorubicin—stomach cancer	0.000354	0.000697	CcSEcCtD
Amantadine—Body temperature increased—Epirubicin—stomach cancer	0.000354	0.000697	CcSEcCtD
Amantadine—Hypersensitivity—Methotrexate—stomach cancer	0.000352	0.000694	CcSEcCtD
Amantadine—Asthenia—Methotrexate—stomach cancer	0.000343	0.000676	CcSEcCtD
Amantadine—Feeling abnormal—Doxorubicin—stomach cancer	0.000341	0.000672	CcSEcCtD
Amantadine—Pruritus—Methotrexate—stomach cancer	0.000338	0.000666	CcSEcCtD
Amantadine—Hypersensitivity—Epirubicin—stomach cancer	0.00033	0.000649	CcSEcCtD
Amantadine—Body temperature increased—Doxorubicin—stomach cancer	0.000327	0.000645	CcSEcCtD
Amantadine—Diarrhoea—Methotrexate—stomach cancer	0.000327	0.000644	CcSEcCtD
Amantadine—Asthenia—Epirubicin—stomach cancer	0.000321	0.000632	CcSEcCtD
Amantadine—Pruritus—Epirubicin—stomach cancer	0.000316	0.000623	CcSEcCtD
Amantadine—Dizziness—Methotrexate—stomach cancer	0.000316	0.000623	CcSEcCtD
Amantadine—Diarrhoea—Epirubicin—stomach cancer	0.000306	0.000603	CcSEcCtD
Amantadine—Hypersensitivity—Doxorubicin—stomach cancer	0.000305	0.000601	CcSEcCtD
Amantadine—Vomiting—Methotrexate—stomach cancer	0.000304	0.000599	CcSEcCtD
Amantadine—Rash—Methotrexate—stomach cancer	0.000301	0.000594	CcSEcCtD
Amantadine—Dermatitis—Methotrexate—stomach cancer	0.000301	0.000593	CcSEcCtD
Amantadine—Headache—Methotrexate—stomach cancer	0.000299	0.00059	CcSEcCtD
Amantadine—Asthenia—Doxorubicin—stomach cancer	0.000297	0.000585	CcSEcCtD
Amantadine—Dizziness—Epirubicin—stomach cancer	0.000296	0.000583	CcSEcCtD
Amantadine—Pruritus—Doxorubicin—stomach cancer	0.000293	0.000577	CcSEcCtD
Amantadine—Vomiting—Epirubicin—stomach cancer	0.000284	0.00056	CcSEcCtD
Amantadine—Nausea—Methotrexate—stomach cancer	0.000284	0.000559	CcSEcCtD
Amantadine—Diarrhoea—Doxorubicin—stomach cancer	0.000283	0.000558	CcSEcCtD
Amantadine—Rash—Epirubicin—stomach cancer	0.000282	0.000556	CcSEcCtD
Amantadine—Dermatitis—Epirubicin—stomach cancer	0.000282	0.000555	CcSEcCtD
Amantadine—Headache—Epirubicin—stomach cancer	0.00028	0.000552	CcSEcCtD
Amantadine—Dizziness—Doxorubicin—stomach cancer	0.000274	0.000539	CcSEcCtD
Amantadine—Nausea—Epirubicin—stomach cancer	0.000266	0.000523	CcSEcCtD
Amantadine—Vomiting—Doxorubicin—stomach cancer	0.000263	0.000518	CcSEcCtD
Amantadine—Rash—Doxorubicin—stomach cancer	0.000261	0.000514	CcSEcCtD
Amantadine—Dermatitis—Doxorubicin—stomach cancer	0.000261	0.000514	CcSEcCtD
Amantadine—Headache—Doxorubicin—stomach cancer	0.000259	0.000511	CcSEcCtD
Amantadine—Nausea—Doxorubicin—stomach cancer	0.000246	0.000484	CcSEcCtD
Amantadine—GRIN2B—Developmental Biology—VEGFA—stomach cancer	7.75e-05	0.000284	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PPP2R1A—stomach cancer	7.74e-05	0.000283	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—TYMP—stomach cancer	7.73e-05	0.000283	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—FADS1—stomach cancer	7.73e-05	0.000283	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—IL6—stomach cancer	7.71e-05	0.000282	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—STAT3—stomach cancer	7.68e-05	0.000281	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—MAPK1—stomach cancer	7.67e-05	0.000281	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—RORA—stomach cancer	7.67e-05	0.000281	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—HTR1A—stomach cancer	7.61e-05	0.000278	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GSTP1—stomach cancer	7.6e-05	0.000278	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—MAPK3—stomach cancer	7.53e-05	0.000275	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	7.53e-05	0.000275	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—IL6—stomach cancer	7.52e-05	0.000275	CbGpPWpGaD
Amantadine—MAOB—Metabolism—HMOX1—stomach cancer	7.49e-05	0.000274	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PGLS—stomach cancer	7.48e-05	0.000274	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—BLVRB—stomach cancer	7.48e-05	0.000274	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—ANXA1—stomach cancer	7.35e-05	0.000269	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—MAPK3—stomach cancer	7.34e-05	0.000268	CbGpPWpGaD
Amantadine—DDC—Metabolism—MTHFR—stomach cancer	7.33e-05	0.000268	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HRH4—stomach cancer	7.3e-05	0.000267	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—WIF1—stomach cancer	7.3e-05	0.000267	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—SREBF2—stomach cancer	7.24e-05	0.000265	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ALDOB—stomach cancer	7.19e-05	0.000263	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—AGTR2—stomach cancer	7.18e-05	0.000263	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—MAPK1—stomach cancer	7.16e-05	0.000262	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—EGFR—stomach cancer	7.16e-05	0.000262	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—MAPK1—stomach cancer	7.15e-05	0.000262	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—RORA—stomach cancer	7.15e-05	0.000262	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PPAP2A—stomach cancer	7.13e-05	0.000261	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—ADRB1—stomach cancer	7.12e-05	0.00026	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—F2R—stomach cancer	7.1e-05	0.00026	CbGpPWpGaD
Amantadine—MAOB—Metabolism—TYMS—stomach cancer	7.06e-05	0.000258	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GSTM1—stomach cancer	6.98e-05	0.000255	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—MAPK1—stomach cancer	6.98e-05	0.000255	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—EGFR—stomach cancer	6.98e-05	0.000255	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HTR1A—stomach cancer	6.91e-05	0.000253	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—TNF—stomach cancer	6.82e-05	0.000249	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—KRAS—stomach cancer	6.76e-05	0.000247	CbGpPWpGaD
Amantadine—DDC—Metabolism—CAV1—stomach cancer	6.76e-05	0.000247	CbGpPWpGaD
Amantadine—DDC—Metabolism—APOA1—stomach cancer	6.74e-05	0.000247	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PRKAB1—stomach cancer	6.74e-05	0.000247	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ALDOB—stomach cancer	6.7e-05	0.000245	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ALOX5—stomach cancer	6.68e-05	0.000244	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—ANXA1—stomach cancer	6.68e-05	0.000244	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—TNF—stomach cancer	6.65e-05	0.000243	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—KRAS—stomach cancer	6.59e-05	0.000241	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—DPYD—stomach cancer	6.58e-05	0.000241	CbGpPWpGaD
Amantadine—MAOB—Metabolism—ERCC2—stomach cancer	6.56e-05	0.00024	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—KISS1—stomach cancer	6.51e-05	0.000238	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RNF43—stomach cancer	6.51e-05	0.000238	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	6.47e-05	0.000237	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—ADRB1—stomach cancer	6.47e-05	0.000236	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—APOA1—stomach cancer	6.43e-05	0.000235	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CKB—stomach cancer	6.36e-05	0.000233	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CA1—stomach cancer	6.36e-05	0.000233	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—NDUFA2—stomach cancer	6.36e-05	0.000233	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—FBP1—stomach cancer	6.36e-05	0.000233	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	6.27e-05	0.000229	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ALOX5—stomach cancer	6.23e-05	0.000228	CbGpPWpGaD
Amantadine—MAOB—Metabolism—MTHFR—stomach cancer	6.17e-05	0.000226	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—HRAS—stomach cancer	6.16e-05	0.000225	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	6.13e-05	0.000224	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—DPYD—stomach cancer	6.13e-05	0.000224	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—APOA1—stomach cancer	6e-05	0.000219	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PLIN2—stomach cancer	5.98e-05	0.000219	CbGpPWpGaD
Amantadine—DDC—Metabolism—PPARG—stomach cancer	5.94e-05	0.000217	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—MAPK1—stomach cancer	5.88e-05	0.000215	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GSTT1—stomach cancer	5.82e-05	0.000213	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CA2—stomach cancer	5.82e-05	0.000213	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	5.81e-05	0.000213	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FST—stomach cancer	5.8e-05	0.000212	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—ADRB2—stomach cancer	5.77e-05	0.000211	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—HRAS—stomach cancer	5.75e-05	0.00021	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CYP2A6—stomach cancer	5.75e-05	0.00021	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—HRAS—stomach cancer	5.74e-05	0.00021	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CAV1—stomach cancer	5.69e-05	0.000208	CbGpPWpGaD
Amantadine—MAOB—Metabolism—APOA1—stomach cancer	5.68e-05	0.000208	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HBEGF—stomach cancer	5.68e-05	0.000208	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—NT5E—stomach cancer	5.67e-05	0.000207	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PGAM1—stomach cancer	5.67e-05	0.000207	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—TP53—stomach cancer	5.66e-05	0.000207	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—HRAS—stomach cancer	5.6e-05	0.000205	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RGS2—stomach cancer	5.6e-05	0.000205	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GAST—stomach cancer	5.6e-05	0.000205	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—AKR1C3—stomach cancer	5.59e-05	0.000205	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	5.54e-05	0.000203	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	5.53e-05	0.000202	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—IL6—stomach cancer	5.5e-05	0.000201	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—MAPK1—stomach cancer	5.48e-05	0.0002	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ENO1—stomach cancer	5.45e-05	0.000199	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GSTT1—stomach cancer	5.42e-05	0.000198	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ALDH7A1—stomach cancer	5.41e-05	0.000198	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PLCE1—stomach cancer	5.41e-05	0.000198	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—IL6—stomach cancer	5.36e-05	0.000196	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	5.36e-05	0.000196	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CYP2A6—stomach cancer	5.36e-05	0.000196	CbGpPWpGaD
Amantadine—DDC—Metabolism—ALB—stomach cancer	5.34e-05	0.000195	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FGG—stomach cancer	5.31e-05	0.000194	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—ADRB2—stomach cancer	5.24e-05	0.000192	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	5.23e-05	0.000191	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—AKR1C3—stomach cancer	5.21e-05	0.000191	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—UMPS—stomach cancer	5.18e-05	0.00019	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—IL6—stomach cancer	5.18e-05	0.00019	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PPP2R1A—stomach cancer	5.13e-05	0.000188	CbGpPWpGaD
Amantadine—DDC—Metabolism—NOS3—stomach cancer	5.11e-05	0.000187	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PRKAA1—stomach cancer	5.11e-05	0.000187	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—ALB—stomach cancer	5.1e-05	0.000186	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ENO1—stomach cancer	5.08e-05	0.000186	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PPARG—stomach cancer	5e-05	0.000183	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RBP4—stomach cancer	4.93e-05	0.00018	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—CXCL8—stomach cancer	4.93e-05	0.00018	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CD44—stomach cancer	4.83e-05	0.000177	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	4.83e-05	0.000177	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PDHA1—stomach cancer	4.82e-05	0.000176	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ECHS1—stomach cancer	4.82e-05	0.000176	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—ALB—stomach cancer	4.75e-05	0.000174	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—HRAS—stomach cancer	4.72e-05	0.000173	CbGpPWpGaD
Amantadine—DDC—Metabolism—PTGS2—stomach cancer	4.68e-05	0.000171	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	4.64e-05	0.00017	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	4.57e-05	0.000167	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—TYMP—stomach cancer	4.53e-05	0.000166	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—FADS1—stomach cancer	4.53e-05	0.000166	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CD44—stomach cancer	4.5e-05	0.000165	CbGpPWpGaD
Amantadine—MAOB—Metabolism—ALB—stomach cancer	4.5e-05	0.000165	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	4.45e-05	0.000163	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—HRAS—stomach cancer	4.4e-05	0.000161	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	4.35e-05	0.000159	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	4.35e-05	0.000159	CbGpPWpGaD
Amantadine—MAOB—Metabolism—NOS3—stomach cancer	4.3e-05	0.000157	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SREBF2—stomach cancer	4.24e-05	0.000155	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HSPB1—stomach cancer	4.24e-05	0.000155	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AGTR2—stomach cancer	4.24e-05	0.000155	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—F2R—stomach cancer	4.19e-05	0.000153	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—BMP2—stomach cancer	4.19e-05	0.000153	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—RORA—stomach cancer	4.19e-05	0.000153	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	4.14e-05	0.000151	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AKR1C3—stomach cancer	4.13e-05	0.000151	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PPP2R1A—stomach cancer	4.11e-05	0.00015	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	4.11e-05	0.00015	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR1A—stomach cancer	4.08e-05	0.000149	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GSTP1—stomach cancer	4.03e-05	0.000147	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—HMOX1—stomach cancer	3.98e-05	0.000145	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PRKCB—stomach cancer	3.95e-05	0.000145	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ANXA1—stomach cancer	3.94e-05	0.000144	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PTGS2—stomach cancer	3.94e-05	0.000144	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ALDOB—stomach cancer	3.93e-05	0.000144	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PPP2R1A—stomach cancer	3.83e-05	0.00014	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ADRB1—stomach cancer	3.82e-05	0.00014	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	3.77e-05	0.000138	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GSTP1—stomach cancer	3.76e-05	0.000137	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—TYMS—stomach cancer	3.75e-05	0.000137	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—HMOX1—stomach cancer	3.71e-05	0.000136	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GSTM1—stomach cancer	3.7e-05	0.000135	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ALOX5—stomach cancer	3.65e-05	0.000134	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	3.65e-05	0.000134	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RPS6—stomach cancer	3.65e-05	0.000133	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—DPYD—stomach cancer	3.59e-05	0.000131	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PRKCB—stomach cancer	3.59e-05	0.000131	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—IL6ST—stomach cancer	3.58e-05	0.000131	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	3.51e-05	0.000129	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—TYMS—stomach cancer	3.49e-05	0.000128	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ERCC2—stomach cancer	3.48e-05	0.000127	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GSTM1—stomach cancer	3.45e-05	0.000126	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HBEGF—stomach cancer	3.35e-05	0.000123	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—MTHFR—stomach cancer	3.27e-05	0.00012	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ERCC2—stomach cancer	3.25e-05	0.000119	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—IL6R—stomach cancer	3.19e-05	0.000117	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTT1—stomach cancer	3.18e-05	0.000116	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—RHOA—stomach cancer	3.17e-05	0.000116	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP2A6—stomach cancer	3.14e-05	0.000115	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ADRB2—stomach cancer	3.09e-05	0.000113	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—AKR1C3—stomach cancer	3.05e-05	0.000112	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—MTHFR—stomach cancer	3.05e-05	0.000112	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PPP2R1A—stomach cancer	3.03e-05	0.000111	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CAV1—stomach cancer	3.02e-05	0.00011	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—APOA1—stomach cancer	3.01e-05	0.00011	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ENO1—stomach cancer	2.98e-05	0.000109	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—RHOA—stomach cancer	2.88e-05	0.000105	CbGpPWpGaD
Amantadine—DDC—Metabolism—PIK3CA—stomach cancer	2.88e-05	0.000105	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SMAD4—stomach cancer	2.82e-05	0.000103	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CAV1—stomach cancer	2.81e-05	0.000103	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—APOA1—stomach cancer	2.81e-05	0.000103	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—CXCL8—stomach cancer	2.79e-05	0.000102	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	2.78e-05	0.000102	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FYN—stomach cancer	2.67e-05	9.78e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PPARG—stomach cancer	2.65e-05	9.71e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CD44—stomach cancer	2.64e-05	9.66e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CXCL8—stomach cancer	2.53e-05	9.25e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FGFR2—stomach cancer	2.51e-05	9.18e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PPARG—stomach cancer	2.47e-05	9.05e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PIK3CA—stomach cancer	2.42e-05	8.86e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ALB—stomach cancer	2.39e-05	8.73e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IRS2—stomach cancer	2.3e-05	8.41e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—NOS3—stomach cancer	2.28e-05	8.35e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PPP2R1A—stomach cancer	2.24e-05	8.21e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CAV1—stomach cancer	2.23e-05	8.15e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ALB—stomach cancer	2.22e-05	8.14e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—APOA1—stomach cancer	2.22e-05	8.13e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTP1—stomach cancer	2.2e-05	8.05e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—HMOX1—stomach cancer	2.17e-05	7.94e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—NOS3—stomach cancer	2.13e-05	7.78e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PRKCB—stomach cancer	2.12e-05	7.76e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IL6ST—stomach cancer	2.11e-05	7.73e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PTGS2—stomach cancer	2.09e-05	7.64e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—TYMS—stomach cancer	2.05e-05	7.49e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—APC—stomach cancer	2.03e-05	7.42e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTM1—stomach cancer	2.02e-05	7.4e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PTGS2—stomach cancer	1.95e-05	7.12e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—MAPK3—stomach cancer	1.94e-05	7.11e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ERCC2—stomach cancer	1.9e-05	6.96e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IL6R—stomach cancer	1.88e-05	6.89e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—MAPK1—stomach cancer	1.85e-05	6.76e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—EGFR—stomach cancer	1.85e-05	6.76e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—MTHFR—stomach cancer	1.79e-05	6.54e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PIK3CA—stomach cancer	1.77e-05	6.46e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SERPINE1—stomach cancer	1.76e-05	6.45e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—KRAS—stomach cancer	1.75e-05	6.39e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RHOA—stomach cancer	1.7e-05	6.23e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NOS3—stomach cancer	1.68e-05	6.16e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CAV1—stomach cancer	1.65e-05	6.03e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—APOA1—stomach cancer	1.65e-05	6.02e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PIK3CA—stomach cancer	1.6e-05	5.87e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ERBB2—stomach cancer	1.58e-05	5.76e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CXCL8—stomach cancer	1.49e-05	5.47e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HRAS—stomach cancer	1.48e-05	5.43e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CDKN1B—stomach cancer	1.46e-05	5.34e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PPARG—stomach cancer	1.45e-05	5.3e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—IL6—stomach cancer	1.42e-05	5.2e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CCND1—stomach cancer	1.39e-05	5.09e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—JUN—stomach cancer	1.39e-05	5.08e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MMP9—stomach cancer	1.35e-05	4.94e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CDKN1A—stomach cancer	1.35e-05	4.93e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MAPK8—stomach cancer	1.31e-05	4.81e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ALB—stomach cancer	1.3e-05	4.77e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PIK3CA—stomach cancer	1.28e-05	4.7e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—NOS3—stomach cancer	1.25e-05	4.56e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—VEGFA—stomach cancer	1.21e-05	4.44e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—STAT3—stomach cancer	1.2e-05	4.4e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PIK3CA—stomach cancer	1.2e-05	4.38e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MAPK3—stomach cancer	1.15e-05	4.2e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PTGS2—stomach cancer	1.14e-05	4.17e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MYC—stomach cancer	1.12e-05	4.08e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MAPK1—stomach cancer	1.09e-05	4e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—EGFR—stomach cancer	1.09e-05	4e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—KRAS—stomach cancer	1.03e-05	3.77e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PIK3CA—stomach cancer	9.48e-06	3.47e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TP53—stomach cancer	9.17e-06	3.35e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HRAS—stomach cancer	8.77e-06	3.21e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IL6—stomach cancer	8.4e-06	3.07e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PIK3CA—stomach cancer	7.02e-06	2.57e-05	CbGpPWpGaD
